Haemonetics HAE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.62B.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Haemonetics's market capitalization?
- Haemonetics (HAE) reported market capitalization of $2.62B in Q1 2026.
- How has Haemonetics's market capitalization changed year-over-year?
- Haemonetics's market capitalization decreased by 18.0% year-over-year, from $3.19B to $2.62B.
- What is the long-term trend for Haemonetics's market capitalization?
- Over 5 years (2021 to 2026), Haemonetics's market capitalization has grown at a -14.3% compound annual growth rate (CAGR), from $5.67B to $2.62B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.